Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-06

Clinical Trial Update: Scenario Tailored Opioid Messaging Program (STOMP) to Improve Risk Understanding in Young Adults [NA]

View source ↗

Summary

A completed clinical trial evaluates a tailored opioid messaging program (STOMP) aimed at improving risk understanding in young adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Michigan | Conditions: Pain, Postoperative, Medication Adherence | NA | Status: COMPLETED | Results posted: 2022-04-06